Brief: Pharmesis International Says Resumption Of Operations At Chengdu Production Facility
Feb 21 (Reuters) - Pharmesis International Ltd PHAR.SI :
* RESUMPTION OF OPERATIONS AT CHENGDU PRODUCTION FACILITY
* PRODUCTION FACILITY IN GULIN, CHINA, REMAINS TEMPORARILY
CLOSED
UNTIL FURTHER NOTICE DUE TO COVID-19 SITUATION.
Source text for Eikon: ID:nSNZ54bvWB
Further company coverage: PHAR.SI
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Pharmesis International
See all newsPharmesis H1 revenue falls 56% amid challenging operating environment
Brief: Pharmesis International Sees Net Loss For HY
Brief: Pharmesis International Says Proposing To Undertake Capital Reduction Exercise
Brief: Pharmesis International Sees Net Profit For 6M & FY Ended 31 Dec 2024
Brief: Pharmesis International Says Unit Entered Conditional Sale And Purchase Agreement